Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live11-14

Health care stocks edged up late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding less than 0.1%.

The iShares Biotechnology ETF (IBB) decreased 0.7%.

In corporate news, Day One Biopharmaceuticals (DAWN) has agreed to buy Mersana Therapeutics (MRSN) in a deal valued at up to about $285 million. Mersana shares surged 210%.

Pfizer (PFE) shares were down 0.4% after it said Thursday it has completed its acquisition of Metsera (MTSR) for about $7 billion in cash plus a contingent value right of up to $20.65 per share tied to the achievement of three specified clinical and regulatory milestones.

BioNTech's (BNTX) collaboration with Pfizer has not changed, Reuters reported Thursday, citing a BioNTech spokesperson who was asked to comment on a media report saying Pfizer may sell its stake in the German biotech company. BioNTech shares were falling 6.8%.

Novo Nordisk (NVO) raised 4 billion euros ($4.7 billion) in a bond sale to help finance its planned acquisition of Akero Therapeutics (AKRO), Bloomberg reported. Novo shares were down 2.5%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment